Published in Methods Enzymol on January 01, 1987
Purification and initial characterization of the lymphoid-cell protein-tyrosine kinase p56lck from a baculovirus expression system. Proc Natl Acad Sci U S A (1991) 1.01
Mutation of proline-1003 to glycine in the epidermal growth factor (EGF) receptor enhances responsiveness to EGF. Mol Biol Cell (1994) 0.82
Physicochemical characterization of the cytoplasmic domain of the epidermal growth factor receptor and evidence for conformational changes associated with its activation by ammonium sulphate. Biochem J (1995) 0.78
An investigation of the role of Glu-842, Glu-844 and His-846 in the function of the cytoplasmic domain of the epidermal growth factor receptor. Biochem J (1995) 0.75
Phosphorylation of synthetic peptides by a tyrosine protein kinase from the particulate fraction of a lymphoma cell line. Proc Natl Acad Sci U S A (1982) 2.25
Epidermal growth factor stimulates the production of phosphatidylinositol monophosphate and the breakdown of polyphosphoinositides in A431 cells. J Biol Chem (1987) 2.04
Phosphoinositides and phosphoinositide-utilizing enzymes in detergent-insoluble lipid domains. Mol Biol Cell (1996) 1.60
Activation of a ribosomal protein S6 protein kinase in Xenopus oocytes by insulin and insulin-receptor kinase. EMBO J (1986) 1.41
Epidermal growth factor stimulates the phosphorylation of synthetic tyrosine-containing peptides by A431 cell membranes. Proc Natl Acad Sci U S A (1982) 1.39
Transforming growth factor and epidermal growth factor stimulate the phosphorylation of a synthetic, tyrosine-containing peptide in a similar manner. J Biol Chem (1982) 1.34
A comparison of the insulin- and epidermal growth factor-stimulated protein kinases from human placenta. J Biol Chem (1984) 1.33
Characterization of platelet-derived growth factor-stimulated phosphorylation in cell membranes. J Biol Chem (1983) 1.31
Compartmentalization of phosphatidylinositol 4,5-bisphosphate in low-density membrane domains in the absence of caveolin. Biochem Biophys Res Commun (1998) 1.30
Activation and desensitization of beta-adrenergic receptor-coupled GTPase and adenylate cyclase of frog and turkey erythrocyte membranes. J Biol Chem (1980) 1.09
Phosphatidylinositol kinase is activated in membranes derived from cells treated with epidermal growth factor. Proc Natl Acad Sci U S A (1987) 1.03
Ligand-induced desensitization of 125I-epidermal growth factor internalization. J Biol Chem (1989) 1.00
Dynamic sensitivity of ATP-sensitive K(+) channels to ATP. J Biol Chem (2001) 1.00
Lack of correlation between changes in polyphosphoinositide levels and actin/gelsolin complexes in A431 cells treated with epidermal growth factor. J Cell Biol (1991) 1.00
Increased phosphorylation of ribosomal protein S6 following microinjection of insulin receptor-kinase into Xenopus oocytes. Nature (1986) 0.98
Purification and characterization of a phosphatidylinositol kinase from A431 cells. Biochemistry (1988) 0.96
Agonist-specific alterations in receptor binding affinity associated with solubilization of turkey erythrocyte membrane beta adrenergic receptors. Mol Pharmacol (1978) 0.96
The multiple endocrine neoplasia type 2B point mutation alters long-term regulation and enhances the transforming capacity of the epidermal growth factor receptor. J Biol Chem (1996) 0.94
Interaction of epidermal growth factor-dependent protein kinase with endogenous membrane proteins and soluble peptide substrate. J Biol Chem (1983) 0.93
Characterization of affinity-purified insulin receptor/kinase. Effects of dithiothreitol on receptor/kinase function. J Biol Chem (1986) 0.88
Substrate specificity and kinetic mechanism of human placental insulin receptor/kinase. Biochemistry (1987) 0.87
Use of cell fusion techniques to probe the mechanism of catecholamine-induced desensitization of adenylate cyclase in frog erythrocytes. Biochim Biophys Acta (1980) 0.86
Purification and characterization of a polyphosphoinositide phosphatase from rat brain. J Biol Chem (1994) 0.85
Rapid increases in the transglutaminase activity of A431 cells following treatment with epidermal growth factor. Biochemistry (1987) 0.84
Serine 1002 is a site of in vivo and in vitro phosphorylation of the epidermal growth factor receptor. J Biol Chem (1993) 0.83
Cell-cycle-dependent modulation of EGF-receptor-mediated signaling. Biochem Biophys Res Commun (1995) 0.82
Mutation of proline-1003 to glycine in the epidermal growth factor (EGF) receptor enhances responsiveness to EGF. Mol Biol Cell (1994) 0.82
Desensitization of the EGF receptor alters its ability to undergo EGF-induced dimerization. Cell Signal (1991) 0.81
Functional characterization of an epidermal growth factor receptor/RET chimera. J Biol Chem (1997) 0.80
Differential effects of GTP on the coupling of beta-adrenergic receptors to adenylate cyclase from frog and turkey erythrocytes. Application of new methods for the analysis of receptor-effector coupling. Biochim Biophys Acta (1979) 0.80
Beta-adrenoreceptors determine affinity but not intrinsic activity of adenylate cyclase stimulants. Nature (1979) 0.79
Growth factors promote inositol uptake in BC3H1 cells. Biochem Biophys Res Commun (1992) 0.78
Correlation of beta-adrenergic receptor-stimulated [3H]GDP release and adenylate cyclase activation. Differences between frog and turkey erythrocyte membranes. J Biol Chem (1981) 0.78
Treatment of A431 cells with epidermal growth factor (EGF) induces desensitization of EGF-stimulated phosphatidylinositol turnover. J Biol Chem (1989) 0.77
Purification and characterization of a cytosolic transglutaminase from a cultured human tumour-cell line. Biochem J (1989) 0.77
Stimulation of purified phosphatidylinositol 4-kinase by cobra venom cardiotoxin. Biochim Biophys Acta (1990) 0.77
Tumor promoter enhances mitogenesis by PDGF with little effect on PDGF binding. J Cell Physiol (1986) 0.76
Multiple effects of N, N' dicyclohexyl carbodiimide on the beta-adrenergic receptor--adenylate cyclase system in frog erythrocytes. J Cyclic Nucleotide Res (1978) 0.76